Literature DB >> 12594266

Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells.

Patricia J Jorritsma1, Jennifer L Brogdon, Kim Bottomly.   

Abstract

Although extracellular signal-regulated kinase (Erk) activation influences IL-4 production in various experimental systems, its role during Th differentiation is unclear. In this study, we show that Erk plays a critical role in IL-4 expression during TCR-induced Th differentiation of naive CD4(+) T cells. Stimulation of CD4(+) T cells with a high affinity peptide resulted in sustained Erk activation and Th1 differentiation. However, reduction of Erk activity led to a dramatic increase in IL-4 production and Th2 generation. Analysis of RNA and nuclear proteins of CD4(+) T cells 48 h after stimulation revealed that this was due to early IL-4 expression. Interestingly, transient Erk activation resulted in altered AP-1 DNA binding activity and the induction of an AP-1 complex that was devoid of Fos protein and consisted of Jun-Jun dimers. These data show that in the presence of a strong TCR signal, IL-4 expression can be induced in naive CD4(+) T cells by altering the strength of Erk activation. In addition, these data suggest that TCR-induced Erk activation is involved in the regulation of IL-4 expression by altering the composition of the AP-1 complex and its subsequent DNA binding activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594266     DOI: 10.4049/jimmunol.170.5.2427

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  ERK1 is important for Th2 differentiation and development of experimental asthma.

Authors:  Nicholas Goplen; Zunayet Karim; Lei Guo; Yonghua Zhuang; Hua Huang; Magdalena M Gorska; Erwin Gelfand; Gilles Pagés; Jacques Pouysségur; Rafeul Alam
Journal:  FASEB J       Date:  2012-01-18       Impact factor: 5.191

2.  Quantitative events determine the differentiation and function of helper T cells.

Authors:  Anne O'Garra; Leona Gabryšová; Hergen Spits
Journal:  Nat Immunol       Date:  2011-04       Impact factor: 25.606

Review 3.  Altered T-cell receptor signaling in the pathogenesis of allergic disease.

Authors:  Shrimati Datta; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

Review 4.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 5.  Differential T-cell receptor signals for T helper cell programming.

Authors:  Penelope A Morel
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

6.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

7.  Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells.

Authors:  Ladislava Sebkova; Antonia Pellicanò; Giovanni Monteleone; Barbara Grazioli; Giovanni Guarnieri; Maria Imeneo; Francesco Pallone; Francesco Luzza
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 8.  The role of diacylglycerol kinases in allergic airway disease.

Authors:  Taku Kambayashi; Deepak A Deshpande
Journal:  Curr Opin Pharmacol       Date:  2020-08-21       Impact factor: 5.547

9.  Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production.

Authors:  M Hanief Sofi; Wei Li; Mark H Kaplan; Cheong-Hee Chang
Journal:  Mol Immunol       Date:  2009-01-31       Impact factor: 4.407

10.  Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.

Authors:  Margarida Saraiva; Jillian R Christensen; Marc Veldhoen; Theresa L Murphy; Kenneth M Murphy; Anne O'Garra
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.